(Reuters) -Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...
British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.